ArticleCancers2021

Amongst Women Stratified to Receive Endocrine Therapy on the Basis of Their Tumor Estrogen and Progesterone Receptor Levels, Those with Higher Tumor Progesterone Receptor Levels Had a Better Outcome Than Those with Lower Levels of Tumor Progesterone Receptor.

Tai-Han Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.